Articles about C15:0 pentadecanoic acid and essential fatty acid health research.
C15
Observational studies consistently link higher C15:0 to lower cardiovascular risk. A 2026 Mendelian randomization study in 7,085 people found no causal effect. Here is what that distinction means.
C15
Fatty15 costs $40/month and its marketing claims run well ahead of the evidence. Two small RCTs, null primary endpoints, and a CEO who is also the lead researcher. Here's an honest look at what the science actually supports.
C15
The 200 mg/day C15:0 target is everywhere — but what does it actually take to reach it from food? We break down per-serving data, the grass-fed multiplier myth, and why the target itself is shakier than it looks.
C15:0
C15:0 has a genuine observational signal across 33 studies and 95,810 people. A 2026 Mendelian randomization study found no causal evidence. Here is what the independent research actually shows.